{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for amphotericin root_codes_url in Code URL (approximate match)
Status:
US Approved Rx
(1988)
Source:
ANDA062838
(1988)
Source URL:
First approved in 1954
Class:
MIXTURE
Status:
US Approved Rx
(2001)
Source:
NDA021265
(2001)
Source URL:
First approved in 1947
Source:
BEROCCA PN by ROCHE
Source URL:
Class:
MIXTURE
Targets:
Conditions:
Retonol, also known as Vitamin A1, is a vitamin found in food and used as a dietary supplement. It is used to treat and prevent vitamin A deficiency. It is also used to prevent further issues in those who have measles. Retinol is used as a metabolic precursor of retinoic acid to treat skin-related conditions, such as cellulite, skin aging, photodamage.
Status:
US Approved OTC
Source:
21 CFR 346.14(a)(4) anorectal:protectant hard fat
Source URL:
First approved in 1983
Source:
ANDA086557
Source URL:
Class:
MIXTURE
Status:
US Approved OTC
Source:
21 CFR 349.12(f) ophthalmic:demulcents povidone
Source URL:
First approved in 1961
Source:
SALPIX POVIDONE by ORTHO
Source URL:
Class:
MIXTURE
Status:
US Approved OTC
Source:
21 CFR 333.110(a) first aid antibiotic:ointment bacitracin
Source URL:
First marketed in 1921
Class:
MIXTURE
Targets:
Conditions:
Bacitracin is a polypeptide antibiotic produced by Bacillus subtilis and Bacillus licheniformis. Bacitracin in combination with neomycin and polymyxin B is indicated for the treatment of many bacterial diseases. The antibacterial properties of bacitracin are mediated by its binding to C55-isoprenyl pyrophosphate, resulting in inhibition of cell wall biosynthesis.
Status:
US Approved OTC
Source:
21 CFR 349.12(c) ophthalmic:demulcents gelatin
Source URL:
First marketed in 1921
Class:
MIXTURE
Status:
US Previously Marketed
Source:
21 CFR 310.527(a) hair loss prevention polysorbate 60
Source URL:
First approved in 1938
Source:
Belladonna and Opium by Bryant Ranch Prepack
Source URL:
Class:
MIXTURE
Status:
US Previously Marketed
Source:
aluminium magnesium silicate
(1921)
Source URL:
First marketed in 1921
Class:
MIXTURE
Status:
Possibly Marketed Outside US
Source:
M005
(1993)
Source URL:
First approved in 1993
Source:
M005
Source URL:
Class:
MIXTURE
Status:
Possibly Marketed Outside US
Source:
Derma Lip Plumper Balm by Pella Pharmaceuticals Co. ltd
(2014)
Source URL:
First approved in 1981
Source:
ANDA086414
Source URL:
Class:
MIXTURE